Literature DB >> 10386990

Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes.

C Verderio1, S Coco, O Rossetto, C Montecucco, M Matteoli.   

Abstract

Tetanus and botulinum toxins bind and are internalized at the neuromuscular junction. Botulinum neurotoxins (BoNTs) enter the cytosol at the motor nerve terminal; tetanus neurotoxin (TeNT) proceeds retroaxonally inside the motor axon to reach the spinal cord inhibitory interneurons. Although the major target of BoNTs is the peripheral cholinergic terminals, CNS neurons are susceptible to intoxication as well. We investigated the route of entry and the proteolytic activity of BoNT/B and BoNT/F in cultured hippocampal neurons and astrocytes. We show that, differently from TeNT, which enters hippocampal neurons via the process of synaptic vesicle (SV) recycling, BoNTs are internalized and cleave the substrate synaptobrevin/VAMP2 via a process independent of synaptic activity. Labeling of living neurons with Texas Red-conjugated BoNTs and fluoresceinated dextran revealed that these toxins enter hippocampal neurons via endocytic processes not mediated by SV recycling. Botulinum toxins also exploit endocytosis to enter cultured astrocytes, where they partially cleave cellubrevin, a ubiquitous synaptobrevin/VAMP isoform. These results indicate that, in spite of their closely related protein structure, TeNT and BoNTs use different routes to penetrate hippocampal neurons. These findings bear important implications for the identification of the protein receptors of clostridial toxins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386990     DOI: 10.1046/j.1471-4159.1999.0730372.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Is there a role for botulinum toxin in the treatment of migraine?

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2003-06

Review 2.  Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.

Authors:  Alexei Verkhratsky; Michela Matteoli; Vladimir Parpura; Jean-Pierre Mothet; Robert Zorec
Journal:  EMBO J       Date:  2016-01-12       Impact factor: 11.598

Review 3.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

4.  Spinal astrocytes produce and secrete dynorphin neuropeptides.

Authors:  Andrew Wahlert; Lydiane Funkelstein; Bethany Fitzsimmons; Tony Yaksh; Vivian Hook
Journal:  Neuropeptides       Date:  2013-01-03       Impact factor: 3.286

Review 5.  Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.

Authors:  Y Bozzi; L Costantin; F Antonucci; M Caleo
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

6.  Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine.

Authors:  Jean-Pierre Mothet; Loredano Pollegioni; Gilles Ouanounou; Magalie Martineau; Philippe Fossier; Gérard Baux
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

Review 7.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

8.  Tetanus toxin blocks the exocytosis of synaptic vesicles clustered at synapses but not of synaptic vesicles in isolated axons.

Authors:  C Verderio; S Coco; A Bacci; O Rossetto; P De Camilli; C Montecucco; M Matteoli
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

9.  Cytosolic calcium oscillations in astrocytes may regulate exocytotic release of glutamate.

Authors:  L Pasti; M Zonta; T Pozzan; S Vicini; G Carmignoto
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 10.  Entering neurons: botulinum toxins and synaptic vesicle recycling.

Authors:  Claudia Verderio; Ornella Rossetto; Carlotta Grumelli; Carolina Frassoni; Cesare Montecucco; Michela Matteoli
Journal:  EMBO Rep       Date:  2006-10       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.